论文部分内容阅读
选择48例糖尿病人行CSⅡ,52例糖尿病人行MSⅡ治疗。结果:CSⅡ组血糖达标时间、胰岛素用量、低血糖发生率明显少于MSⅡ组。两组比较有显著性差异。结论:CSⅡ治疗优于MSⅡ。
Forty-eight diabetic patients underwent CSⅡ and 52 diabetic patients underwent MSⅡ. Results: The blood glucose level, insulin dosage, and incidence of hypoglycemia in CS Ⅱ group were significantly lower than those in MS Ⅱ group. There were significant differences between the two groups. Conclusion: CS Ⅱ is better than MS Ⅱ.